Overview

Tranexamic Acid in Off-pump Coronary Surgery

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The aim of this prospective, randomized, double-blinded, placebo-controlled study was to evaluate the effects of tranexamic acid, a synthetic antifibrinolytic drug, on the postoperative bleeding and transfusion requirements in patients undergoing off-pump coronary artery bypass graphing (OPCAB) surgery.
Phase:
N/A
Details
Lead Sponsor:
Chinese Academy of Medical Sciences, Fuwai Hospital
Treatments:
Tranexamic Acid